Elequin Capital LP Mirum Pharmaceuticals, Inc. Transaction History
Elequin Capital LP
- $1.04 Billion
- Q1 2024
A detailed history of Elequin Capital LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Elequin Capital LP holds 245,696 shares of MIRM stock, worth $8.4 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
245,696
Previous 93
264089.25%
Holding current value
$8.4 Million
Previous $2,000
308450.0%
% of portfolio
0.6%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$222 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$149 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$113 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$96.5 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$94.6 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.26B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...